pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
◐
Sign In
Subscribe
🐶
home
jobs
news
search
EMERGENT · news · pharmadog
← back to EMERGENT
News mentioning EMERGENT
18
stories
1d
Early Alert: Intraosseous Needle Set Issue from Becton Dickinson
fda medwatch
6d
MapLight CEO on what investors missed in the biotech’s schizophrenia data
biopharma dive
8d
MapLight dives despite positive data for schizophrenia drug
biopharma dive
8d
MapLight’s schizophrenia pill remains in Cobenfy’s shadow after mixed Phase 2 readout
biospace
13d
Arrowhead hits ‘best-case scenario’ with latest results for fat-lowering drug
biopharma dive
Jun 26, 26
Alkermes’ incoming CEO has a plan to outplay Lilly and Takeda
biopharma dive
Jun 17, 26
FDA Approves First Single-Dose Generic Treatment for Influenza
fda press
Jun 5, 26
Study data convince Lundbeck to push new migraine drug forward
biopharma dive
Jun 5, 26
Opinion: How living and practicing medicine abroad complicated my beliefs about universal health care systems
stat
Jun 1, 26
Opinion: What should hospitals do when patients demand unvaccinated donor blood?
stat
May 13, 26
Dr Bockorny on the Rationale for Targeting CCR8 in Solid Tumors
onclive
May 12, 26
Dr McCann on the FDA Approval of Vepdegestrant for ESR1-Mutated, ER+ Advanced Breast Cancer
onclive
May 12, 26
Dr Postow on an Ideal Post-ICI Monitoring Framework in Melanoma
onclive
May 12, 26
Dr Postow on the Timing of Delayed or Re-Emergent irAEs in Melanoma
onclive
May 8, 26
Poll Results Highlight Breast Cancer Abstracts of Interest at ASCO 2026
onclive
May 6, 26
ASCO 2026 HR+ and HER2+ Breast Cancer Preview: Read up on the Insights to Know Before You Go
onclive
Apr 27, 26
Oruka surges as long-acting psoriasis drug shows early promise
biopharma dive
Apr 27, 26
Intellia CRISPR drug succeeds in late-stage study against rare swelling disorder
biopharma dive
